Sesame Summit 2026 – application open

Self.co raises €2.56M for accessible allergy testing in Europe

Nearly half of Europeans struggle with allergy misdiagnosis, creating a healthcare gap that costs both patients and systems dearly. This diagnostic challenge has caught the attention of European investors, particularly as personalised healthcare becomes increasingly prioritised across EU markets. Lithuanian startup Self.co has secured €2.56 million in funding to tackle this widespread issue, making allergy testing more accessible to European consumers.

The funding round positions Self.co at the forefront of Europe’s growing digital health movement, where regulatory frameworks like the Medical Device Regulation create both opportunities and compliance requirements that favour well-prepared startups.

Lithuanian startup funding round attracts European venture capital

Iron Wolf Capital led this significant investment, demonstrating the growing confidence in Baltic tech innovation. The Lithuanian VC’s involvement signals a broader trend of regional capital backing local solutions to pan-European problems. Iron Wolf’s portfolio strategy focuses on B2B and healthcare technology, making Self.co a natural fit for their thesis around accessible medical solutions.

“We’re seeing unprecedented demand for at-home diagnostic solutions across Europe, and Self.co’s approach to allergy testing addresses a genuine market need,” noted a representative from the investment team. The funding structure reflects typical European Series A characteristics, with local lead investors bringing both capital and market knowledge essential for navigating Europe’s fragmented healthcare systems.

The investor mix suggests confidence in Self.co’s ability to scale across European markets, where healthcare regulations vary significantly between member states. This regulatory complexity often favours startups that can demonstrate compliance early in their development cycle.

Digital health innovation tackles European allergy crisis

Self.co’s platform addresses a critical gap in European healthcare delivery, where traditional allergy testing often requires lengthy waits and specialist appointments. The company’s solution enables consumers to conduct reliable allergy tests from home, potentially reducing the diagnostic timeline from months to days. This approach particularly resonates in Nordic and Baltic markets, where healthcare digitisation has accelerated post-pandemic.

The startup competes in a growing European market that includes established players like Thriva and emerging digital health platforms. However, Self.co’s specific focus on allergy testing provides clear differentiation in a sector where specialisation often trumps broad-spectrum offerings. Their technology integrates with existing healthcare systems, crucial for adoption in Europe’s diverse medical landscapes.

“Our goal is to make allergy testing as simple as checking your blood pressure at home,” explained the Self.co team regarding their European expansion strategy. The funding will primarily support product development and regulatory approvals across key EU markets, starting with Germany and the Netherlands where digital health adoption rates remain high.

This investment reflects Europe’s broader shift toward preventive healthcare solutions, supported by regulatory frameworks that increasingly favour patient-centric innovation. Self.co’s timing aligns with EU digital health initiatives that prioritise accessible, data-driven medical solutions for common conditions like allergies.

you might also like

Fundraising 4 hours ago

London-based AI laboratory Ineffable Intelligence has emerged from stealth with a $1.1 billion seed round at a $5.1 billion post-money valuation, the company confirmed on 27 April 2026. The financing is the largest seed round ever raised by a European company and one of the largest first-money-in rounds in the global history of artificial intelligence. The round was co-led by Sequoia Capital and Lightspeed Venture Partners. Participating investors included Nvidia, DST Global, Index Ventures, Google, and the UK Sovereign AI Fund, the British government’s recently established vehicle for backing strategic AI capacity on home soil. A bet on a different path to general intelligence Ineffable Intelligence was founded in 2025 by David Silver, the former Vice President of Reinforcement Learning at Google DeepMind and the principal architect of AlphaGo, AlphaZero and AlphaStar. He is joined by three further DeepMind alumni: Wojciech Czarnecki, Lasse Espeholt and Junhyuk Oh. All four have spent the past decade at the frontier of reinforcement learning research, the discipline behind some of the most consequential demonstrations of machine learning over the past ten years. The company describes its objective as building a “superlearner” — an AI system capable of acquiring knowledge directly from its own experience rather than from human-generated text or imagery. “Our mission is to make first contact with superintelligence,” Silver said in a statement accompanying the launch. “We are creating a superlearner that discovers all knowledge from its own experience, from elementary motor skills through to profound intellectual breakthroughs.” The framing is a deliberate departure from the dominant industry trajectory. Most leading AI laboratories, including OpenAI, Anthropic and Google DeepMind itself, have built large language models trained primarily on the corpus of the internet, then refined that training with human feedback. Ineffable’s wager is that the marginal returns on scaling text-based pretraining are diminishing and that the next leap in capability will come from agents that learn endlessly from the consequences of their own actions, in much the same way AlphaZero learnt the game of Go without studying any human matches. Why $1.1 billion at seed The size of the round is unusual even by the inflated standards of the 2026 AI capital cycle. Two factors appear to explain it. First, frontier reinforcement learning at the scale Ineffable describes is computationally extraordinarily expensive: the company will need to operate vast simulation environments and train very large models against them, an undertaking that consumes capital at a rate closer to physical R&D than to traditional software. Second, the round signals a strategic move by Europe’s investor and policy ecosystems to retain the most ambitious AI researchers on the continent. The presence of the UK Sovereign AI Fund alongside Sequoia, Lightspeed and Nvidia is the clearest expression of that intent. The British government has publicly framed the investment as a bet on breakthrough AI that “can discover new knowledge”, positioning the country as a willing co-investor in domestic frontier laboratories. For Ineffable, the implication is access not only to capital but to compute, regulatory engagement and the still-resilient academic talent base around UCL, Oxford, Cambridge and Imperial. Founder pledge of historic scale Alongside the funding announcement, Silver disclosed that he is committing 100 per cent of any personal proceeds from his Ineffable equity to charity via the Founders Pledge network — described by the organisation as the largest pledge in its history. At the round’s $5.1 billion valuation, that commitment could ultimately exceed several billion dollars if the company succeeds. It is a meaningful gesture in a sector where the reputational stakes around concentrated AI wealth are escalating, and one likely to be referenced in subsequent founder-led commitments. Implications for the European AI landscape Ineffable’s emergence reshapes the European AI map in three concrete ways. It establishes London as the home of the continent’s largest-ever seed-stage company, complicating Paris’s recent narrative of frontier-AI primacy after Mistral’s earlier rounds. It validates a thesis — that reinforcement learning, not transformer scaling, is the next frontier — that has lately been losing capital share to language-model incumbents. And it confirms that the UK government is now willing to act as a balance-sheet co-investor in domestic AI laboratories, a posture much closer to the French model than to the predominantly grant-based regimes elsewhere in Europe. The execution risk is non-trivial. Reinforcement learning at frontier scale has historically required years of careful environment design before producing competitive systems, and Ineffable’s “first contact” framing sets a high bar against which it will be judged. But for now, with a billion dollars on the balance sheet, four of the discipline’s most accomplished researchers in the founding team and a sovereign co-investor at its back, Ineffable Intelligence is the most heavily resourced new entrant in the European AI cycle. Sesamers covers European fundraising rounds across deeptech, fintech and AI. Source: tech.eu.

Fundraising 5 days ago

Belfast's Cloudsmith has raised $72M Series C led by TCV, with Insight Partners participating, to expand its artifact management platform and secure the AI-era software supply chain.

Fundraising 5 days ago

Berlin’s VREY has raised €3.3M seed led by Rubio Impact Ventures to roll out rooftop solar software for Germany’s multi-family buildings.

Subscribe to
our Newsletter!

Stay at the forefront with our curated guide to the best upcoming Tech events.